Published in World J Gastroenterol on February 28, 2010
Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomedicine (2015) 1.00
Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.90
Biodegradable Polymersomes for the Delivery of Gemcitabine to Panc-1 Cells. J Pharm (Cairo) (2015) 0.75
Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine (2008) 4.59
Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target (2007) 2.50
Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release (2004) 2.43
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine (2006) 2.07
Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res (2007) 1.77
Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther (2006) 1.61
Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. J Control Release (2003) 1.22
The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov Today (2008) 1.15
Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery. Nanomedicine (2007) 1.14
Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Pharmazie (2006) 1.10
A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types. J Control Release (2007) 1.06
Folate-functionalized polymeric micelles for tumor targeted delivery of a potent multidrug-resistance modulator FG020326. J Biomed Mater Res A (2008) 1.00
Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use. Int J Pharm (2006) 0.99
Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors. Pharmacogenomics (2009) 0.96
Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification. Bioconjug Chem (2007) 0.93
Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes. Curr Drug Deliv (2007) 0.92
Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice. World J Gastroenterol (2005) 0.89
Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties. J Nanosci Nanotechnol (2006) 0.87
The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles. Arch Pharm Res (2008) 0.87
Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor. Mol Pharm (2009) 0.87
Protective properties of melatonin-loaded nanoparticles against lipid peroxidation. Int J Pharm (2004) 0.86
PEGylated Nanoparticles based on a polyaspartamide. preparation, physico-chemical characterization, and intracellular uptake. Biomacromolecules (2006) 0.82
Synthesis and characterization of poly(ethylene glycol)-poly(D,L-lactide-co-glycolide) poly(ethylene glycol) tri-block co-polymers modified with collagen: a model surface suitable for cell interaction. J Biomater Sci Polym Ed (2006) 0.82
Unimolecular, soluble semiconductor nanoparticle-based biosensors for thrombin using charge/electron transfer. Bioconjug Chem (2008) 0.80
Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles. Drug Deliv (2008) 0.79
In vitro and in vivo behaviour of biodegradable and injectable PLA/PGA copolymers related to different matrices. Int J Artif Organs (2007) 0.79
Poly(lactic acid) (PLA) based nanocomposites--a novel way of drug-releasing. Biomed Mater (2007) 0.78
Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer. Recent Pat Anticancer Drug Discov (2009) 0.77
Investigation of the incidence of pancreatic cancer-related depression and its relationship with the quality of life of patients. Digestion (2010) 1.60
Bmi-1 expression predicts prognosis for patients with gastric carcinoma. J Surg Oncol (2008) 1.31
Clinical features and risk factors of patients with fatty liver in Guangzhou area. World J Gastroenterol (2004) 0.94
Incidence and clinical features of hyperlipidemic acute pancreatitis from Guangdong, China: a retrospective multicenter study. Pancreas (2014) 0.92
Surveillance of intra-abdominal pressure and intestinal barrier function in a rat model of acute necrotizing pancreatitis and its potential early therapeutic window. PLoS One (2013) 0.82
Infliximab enhances the therapeutic effectiveness of octreotide on acute necrotizing pancreatitis in rat model. Pancreas (2012) 0.82
Higher expression patterns of the intestinal stem cell markers Musashi-1 and hairy and enhancer of split 1 and their correspondence with proliferation patterns in the mouse jejunum. Med Sci Monit (2010) 0.81
Experimental ablation of the pancreas with high intensity focused ultrasound (HIFU) in a porcine model. Int J Med Sci (2010) 0.81
Infliximab: protective effect to intestinal barrier function of rat with acute necrosis pancreatitis at early stage. Pancreas (2013) 0.81
The clinical-psychological features of functional dyspepsia patients with weight loss: a multi-center study from China. Digestion (2015) 0.79
A combination of models for end-stage liver disease and cirrhosis-related complications to predict the prognosis of liver cirrhosis. Clin Res Hepatol Gastroenterol (2012) 0.79
Musashi1 expression cells derived from mouse embryonic stem cells can be enriched in side population isolated by fluorescence activated cell sorter. BMC Cell Biol (2011) 0.78
Musashi 1-positive cells derived from mouse embryonic stem cells can differentiate into neural and intestinal epithelial-like cells in vivo. Cell Biol Int (2010) 0.78
Antiviral therapy of decompensated hepatitis B virus-related cirrhosis. Chin Med J (Engl) (2012) 0.77
Effect of amitriptyline on gastrointestinal function and brain-gut peptides: a double-blind trial. World J Gastroenterol (2013) 0.77
Musashi1 and hairy and enhancer of split 1 high expression cells derived from embryonic stem cells enhance the repair of small-intestinal injury in the mouse. Dig Dis Sci (2011) 0.77
[Relationship between symptoms of pancreatic cancer-related depression and quality of life of patients]. Zhonghua Yi Xue Za Zhi (2009) 0.77
[Epidemiological investigation on an outbreak of amoebic dysentery in Jiangshan City of Zhejiang Province]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (2009) 0.76
Effect of low-dose amitriptyline on globus pharyngeus and its side effects. World J Gastroenterol (2013) 0.75
[The inhibitive effects of 5-fluorouracil-loaded polylactic acid nanoparticles on human Tenon's capsule fibroblast in vitro]. Zhonghua Yan Ke Za Zhi (2009) 0.75
[Postoperative abdominal endogenic field hyperthermia combined with FOLFOX regimen in the treatment of 68 cases of advanced gastric cancer]. Nan Fang Yi Ke Da Xue Xue Bao (2007) 0.75
[Comparison of biological phosphorus removal between different systems using O2, NO3(-) and NO2(-) as electron acceptors]. Huan Jing Ke Xue (2009) 0.75